Persistent ascites resolving with gonadotropin-releasing-hormone-agonist 18 months after hospitalization for severe ovarian hyperstimulation syndrome

被引：5
作者：
Comba, Cihan [1 ]
Ugurlucan, Funda Gungor [1 ]
Bastu, Ercan [1 ]
Iyibozkurt, Ahmet Cem [1 ]
Topuz, Samet [1 ]
机构：
[1] Istanbul Univ, Istanbul Tip Fak, Kadin Hastaliklari & Dogum Anabilim Dali, TR-34093 Istanbul, Turkey
来源：
ARCHIVES OF GYNECOLOGY AND OBSTETRICS | 2014年 / 289卷 / 01期
关键词：
Ovarian hyperstimulation syndrome; Ascites; Infertility; Ovarian stimulation; HIGH-RISK PATIENTS; OOCYTE MATURATION; GNRH ANTAGONIST; PREVENTION; INDUCTION; WOMEN; SURGE;
D O I：
10.1007/s00404-013-2940-7
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Ovarian hyperstimulation syndrome (OHSS) is a life- threatening complication of controlled ovarian stimulation. One of the main symptoms of OHSS is ascites. Treatment is symptomatic with resolution of the symptoms over days to weeks. We report a case of severe OHSS with persistent ascites 18 months after the diagnosis. Persistent ascites secondary to OHSS was diagnosed and single dose leuprolide acetate depot 11.25 mg was administered. At follow-up, no ascites was observed.
引用
收藏
页码：223 / 225
页数：3
相关论文
共 12 条
  • [1] Abramov Y, 1996, HUM REPROD, V11, P1381
  • [2] Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting
    DiLuigi, Andrea J.
    Engmann, Lawrence
    Schmidt, David W.
    Maier, Donald B.
    Nulsen, John C.
    Benadiva, Claudio A.
    [J]. FERTILITY AND STERILITY, 2010, 94 (03) : 1111 - 1114
  • [3] Dugernier T, 2000, ACTA GASTRO-ENT BELG, V63, P264
  • [4] The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study
    Engmann, Lawrence
    DiLuigi, Andrea
    Schmidt, David
    Nulsen, John
    Maier, Donald
    Benadiva, Claudio
    [J]. FERTILITY AND STERILITY, 2008, 89 (01) : 84 - 91
  • [5] Physiology and Pathology of Ovarian Hyperstimulation Syndrome
    Gomez, Raul
    Soares, Sergio R.
    Busso, Cristiano
    Garcia-Velasco, Juan A.
    Simon, Carlos
    Pellicer, Antonio
    [J]. SEMINARS IN REPRODUCTIVE MEDICINE, 2010, 28 (06) : 448 - 457
  • [6] ITSKOVITZ J, 1991, FERTIL STERIL, V56, P213
  • [7] Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report
    Itskovitz-Eldor, J
    Kol, S
    Mannaerts, B
    [J]. HUMAN REPRODUCTION, 2000, 15 (09) : 1965 - 1968
  • [8] Gonadotropin-releasing hormone agonist administration reduced vascular endothelial growth factor (VEGF), VEGF receptors, and vascular permeability of the ovaries of hyperstimulated rats
    Kitajima, Y
    Endo, T
    Manase, K
    Nishikawa, A
    Shibuya, M
    Kudo, R
    [J]. FERTILITY AND STERILITY, 2004, 81 : 842 - 849
  • [9] Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome
    Kol, S
    [J]. FERTILITY AND STERILITY, 2004, 81 (01) : 1 - 5
  • [10] Kumar Pratap, 2011, J Hum Reprod Sci, V4, P70, DOI 10.4103/0974-1208.86080
12